Management of fusiform ascending aortic aneurysms.
Thirteen patients had elective surgical treatment of fusiform ascending aortic aneurysms at Strong Memorial and Rochester General Hospitals from 1970 to 1978. There were 8 men and 5 women ranging in age from 51 to 78 years (mean, 61 years). Nine patients underwent composite tube graft and aortic valve replacement, 3 had aortic valve replacement plus supracoronary tube grafts, and 1 had aortic valve replacement plus aneurysmorrhaphy. Coronary reimplantation alone or combined with saphenous vein bypasses was fashioned in 10 patients. Potassium cardioplegia was considered a useful adjunct in 6 patients. Two early deaths accounted for an operative mortality of 15.4%. There were 3 late deaths. Eight patients are alive and well 2 to 109 months after operation.
D000368:Aged; D001011:Aorta / Q000601:surgery; D001014:Aortic Aneurysm / Q000150:complications / Q000401:mortality / Q000601:surgery*; D001021:Aortic Valve / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D001026:Coronary Artery Bypass; D003331:Coronary Vessels / Q000601:surgery; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging; D006324:Heart Arrest, Induced; D006333:Heart Failure / Q000150:complications; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011093:Polyethylene Terephthalates; D011859:Radiography
D011093:Polyethylene Terephthalates